Severe Asthma 2018: Advances in Pathogenesis and Treatment

 

Severe Asthma 2018: Advances in Pathogenesis and Treatment
Avatar

TYRO3 Receptor Tyrosine Kinase is a Negative Regulator of Type 2 Immunity

By Severe Asthma 2018: Advances in Pathogenesis and Treatment FEATURING Carla Rothlin
By Severe Asthma 2018: Advances in Pathogenesis and Treatment FEATURING Carla Rothlin
144 views
October 30, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

09:07
GSK

Identifying Eosinophilic Granulomatosis With Polyangiitis and Hypere…

Feat. M. O'Connor

Featured Video

12:33
GSK

A Treatment Option for Chronic Rhinosinusitis With Nasal Polyps

Feat. C. Franzese
Videos
13:49
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Asthma Management Overview

Feat. L. Cohn
16:41
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Breaking Barriers: Mechanisms and Consequences of Epithelial Barrier…

Feat. S. Georas
11:03
Severe Asthma 2018: Advances in Pathogenesis and Treatment

In Vivo Models of Epithelial Barrier Function

Feat. S. Georas
26:26
Severe Asthma 2018: Advances in Pathogenesis and Treatment

TYRO3 Receptor Tyrosine Kinase is a Negative Regulator of Type 2 Imm…

Feat. C. Rothlin
10:31
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Parsing the Heterogeneity of Immune Responses in Severe Asthma

Feat. A. Ray
14:10
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Next Generation Therapy in Severe Asthma: Identifying Targets to Sup…

Feat. A. Ray
11:26
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Leveraging Epigenetic Data to Understand the Asthma Trajectory

Feat. D. Vercelli
17:07
Severe Asthma 2018: Advances in Pathogenesis and Treatment

From Mom to Baby: Epigenetics and the Trajectory to Childhood Asthma

Feat. D. Vercelli
29:38
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Spontaneous Protein Crystallization as a Novel Therapeutic Target in…

Feat. B. Lambrecht
25:58
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Next Generation Biologics for Severe Asthma: Targeting the Chitinase…

Feat. G. Chupp
08:25
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Se…

Feat. G. Chupp
22:33
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Severe Asthma Subgroups with High YKL-40

Feat. J. Gomez-Villalobos
05:37
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Asthma-COPD Overlap: Myth or Reality?

Feat. B. Celli
17:03
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Asthma-COPD Overlap: Why is this Overlap a Problem?

Feat. B. Celli
08:45
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Immunotherapy for Food Allergy: Key Concepts

Feat. J. Wang
09:02
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Oral Immunotherapy (OIT) for Food Allergy

Feat. J. Wang
06:58
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Sublingual and Epicutaneous Immunotherapy for Food Allergy

Feat. J. Wang
10:31
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Use of Biologics in Severe Food Allergies

Feat. J. Wang
22:51
Severe Asthma 2018: Advances in Pathogenesis and Treatment

Severe Asthma: Advances in Pathogenesis and Treatment Discussion

Feat. L. Cohn